NIH, CDC Leaders Urge Congress To Quickly Approve Zika Funding; Bill Package Introduced In U.S. House Would Provide Vaccine Development Incentives

Bloomberg BNA: Zika Vaccine Developer Would Get Tax Credit Under House Bill
“Drug companies that develop a Zika virus vaccine could be eligible for a tax credit under a slate of bills introduced in the House Feb. 12 designed to reduce the spread of the mosquito-borne virus. Rep. Curt Clawson (R-Fla.) said he introduced a three-part legislative package on Zika to combat a virus that has spread to more than 30 nations throughout the Americas as a multipronged approach to prevent Zika infection, to ensure that the disease doesn’t become prevalent in the U.S., and to ensure that localities are prepared to deal with any instances of outbreak as they arise…” (Baumann, 2/16).

CQ News: NIH, CDC Push Lawmakers to Fund Zika Request Promptly
“Top federal health officials warned Congress Wednesday that they will not be able to effectively carry out a long-term response to the escalating Zika virus crisis if lawmakers don’t provide additional cash — quickly. The National Institutes of Health and Centers for Disease Control and Prevention chiefs also outlined steps that are already underway to combat the emerging Zika virus as they wait for lawmakers to act on an emergency funding request…” (Zanona, 2/17).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.